Zeh HJ - Search Results

1

PAMPs and DAMPs: signal 0s that spur autophagy and immunity.

Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. Tang D, et al. Among authors: zeh hj. Immunol Rev. 2012 Sep;249(1):158-75. doi: 10.1111/j.1600-065X.2012.01146.x. Immunol Rev. 2012. PMID: 22889221 Free PMC article. Review.

2

Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.

Lotze MT, Zeh HJ 3rd, Elder EM, Cai Q, Pippin BA, Rosenstein MM, Whiteside TL, Herberman R. Lotze MT, et al. Among authors: zeh hj 3rd. J Immunother (1991). 1992 Oct;12(3):212-7. doi: 10.1097/00002371-199210000-00015. J Immunother (1991). 1992. PMID: 1359903

3

New biologic agents come to bat for cancer therapy.

Lotze MT, Rubin JT, Zeh HJ. Lotze MT, et al. Among authors: zeh hj. Curr Opin Oncol. 1992 Dec;4(6):1116-23. Curr Opin Oncol. 1992. PMID: 1457526 Review.

4

Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution.

Storkus WJ, Zeh HJ 3rd, Salter RD, Lotze MT. Storkus WJ, et al. Among authors: zeh hj 3rd. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):94-103. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7506576

5

Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.

Storkus WJ, Zeh HJ 3rd, Maeurer MJ, Salter RD, Lotze MT. Storkus WJ, et al. Among authors: zeh hj 3rd. J Immunol. 1993 Oct 1;151(7):3719-27. J Immunol. 1993. PMID: 7690811

6

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

Tahara H, Zitvogel L, Storkus WJ, Zeh HJ 3rd, McKinney TG, Schreiber RD, Gubler U, Robbins PD, Lotze MT. Tahara H, et al. Among authors: zeh hj 3rd. J Immunol. 1995 Jun 15;154(12):6466-74. J Immunol. 1995. PMID: 7759882

7

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

Tahara H, Zeh HJ 3rd, Storkus WJ, Pappo I, Watkins SC, Gubler U, Wolf SF, Robbins PD, Lotze MT. Tahara H, et al. Among authors: zeh hj 3rd. Cancer Res. 1994 Jan 1;54(1):182-9. Cancer Res. 1994. PMID: 7903204

8

Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer.

Zeh HJ 3rd, Hurd S, Storkus WJ, Lotze MT. Zeh HJ 3rd, et al. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):155-61. doi: 10.1097/00002371-199308000-00012. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7904180

9

Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2.

Zeh HJ 3rd, Leder GH, Lotze MT, Salter RD, Tector M, Stuber G, Modrow S, Storkus WJ. Zeh HJ 3rd, et al. Hum Immunol. 1994 Feb;39(2):79-86. doi: 10.1016/0198-8859(94)90105-8. Hum Immunol. 1994. PMID: 8175386

10

Addicted to death: invasive cancer and the immune response to unscheduled cell death.

Zeh HJ 3rd, Lotze MT. Zeh HJ 3rd, et al. J Immunother. 2005 Jan-Feb;28(1):1-9. doi: 10.1097/00002371-200501000-00001. J Immunother. 2005. PMID: 15614039 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page